SC
SPPI

Sculptor Capital’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Sculptor Capital’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-115,600
Closed -$1.02M – 829
2013
Q4 		$1.02M Hold
115,600
– – ﹤0.01% 678
2013
Q3 		$969K Hold
115,600
– – ﹤0.01% 644
2013
Q2 		$862K Buy
+115,600
New +$887K ﹤0.01% 606

Other funds holding SPPI

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
FCAM
F&C Asset Management Edinburgh, Scotland, United Kingdom $7.92B AUM 24.35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sculptor Capital's SPPI Position: Q1 2014 in Review

Sculptor Capital sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2014, closing a stake of 115,600 shares — an estimated $1.02M sold.

Sculptor Capital first reported a position in SPPI in Q2 2013 and held it in 3 quarters. The position peaked at $1.02M in Q4 2013. 119 funds tracked by Wall St. Rank hold SPPI as of Q1 2014.

  • Sculptor Capital reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2014 after selling out during the quarter.
  • Sculptor Capital sold 115,600 Spectrum Pharmaceuticals Inc shares in Q1 2014, an estimated $1.02M.
  • Sculptor Capital first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 3 quarters.
  • Sculptor Capital's Spectrum Pharmaceuticals Inc position peaked at $1.02M in Q4 2013.
  • 119 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2014.

Based on Sculptor Capital's 13F filing for Q1 2014, filed 15 May 2014.